Document Detail


Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease.
MedLine Citation:
PMID:  19687017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The seventh Committee on "Biological Effects of Ionizing Radiation" (BEIR VII, 2006) underlines "the need of studies of infants who are exposed to diagnostic radiation because catheters have been placed in their hearts". OBJECTIVE: To determine the lifetime attributable risk (LAR) of cancer associated with the estimated cumulative radiological dose in 59 children (42 male, age 2.8+/-3.2 years) with complex congenital heart disease, and to assess chromosomal DNA damage after cardiac catheterisation procedures. Methods In all patients, the cumulative exposure was estimated as effective dose in milliSievert (mSv), and LAR cancer was determined from the BEIR VII report. In a subset of 18 patients (13 male, age 5.2+/-5.7 years) micronucleus as a biomarker of DNA damage and long-term risk predictor of cancer was assayed before and 2 h after catheterisation procedures. Dose-area product (Gy cm(2)) was assessed as a measure of patient dose. RESULTS: The median life time cumulative effective dose was 7.7 mSv per patient (range 4.6-41.2). Cardiac catheterisation procedures and CT were responsible for 95% of the total effective dose. For a 1-year-old child, the LAR cancer was 1 in 382 (25th to 75th centiles: 1 in 531 to 1 in 187) and 1 in 156 (25th to 75th centiles: 1 in 239 to 1 in 83) for male and female patients, respectively. Median micronucleus values increased significantly after the procedure in comparison with baseline (before 6 per thousand vs after 9 per thousand, p=0.02). The median dose-area product value was 20 Gy cm(2) (range 1-277). CONCLUSION: Children with congenital heart disease are exposed to a significant cumulative dose. Indirect cancer risk estimations and direct DNA data both emphasise the need for strict radiation dose optimisation in children.
Authors:
Lamia Ait-Ali; Maria Grazia Andreassi; Ilenia Foffa; Isabella Spadoni; Eliseo Vano; Eugenio Picano
Related Documents :
22241947 - Update of a comparative analysis of cost minimization following the introduction of new...
16050837 - Anticipation of radiation dose to the conceptus from occupational exposure of pregnant ...
3393627 - Quantitative aspects of the interactive killing effects between x rays and other mutage...
3570807 - Epistemological problems in assessing cancer risks at low radiation doses.
2177647 - Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added...
20646767 - Effects of chronic uranium exposure on life history and physiology of daphnia magna ove...
Publication Detail:
Type:  Journal Article     Date:  2009-08-16
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  96     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-02     Completed Date:  2010-04-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  269-74     Citation Subset:  AIM; IM    
Affiliation:
CNR Institute of Clinical Physiology, G Pasquinucci Hospital, Via Aurelia Sud-Montepepe, 54100 Massa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Child
Child, Preschool
DNA / radiation effects
DNA Damage*
Female
Heart Catheterization / adverse effects
Heart Defects, Congenital / radiography*
Humans
Infant
Male
Neoplasms, Radiation-Induced / etiology*
Radiation Dosage
Radiation Injuries / etiology*
Risk Factors
Chemical
Reg. No./Substance:
9007-49-2/DNA
Comments/Corrections
Comment In:
Heart. 2010 Feb;96(4):251-2   [PMID:  19875368 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
Next Document:  The factors involved in the progress of preclinical atherosclerosis associated with systemic lupus e...